Compare KOPN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOPN | OSUR |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.9M | 177.2M |
| IPO Year | 1992 | 1986 |
| Metric | KOPN | OSUR |
|---|---|---|
| Price | $2.55 | $2.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $4.25 | $3.00 |
| AVG Volume (30 Days) | ★ 2.7M | 851.7K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $45,602,295.00 | ★ $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $43.33 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.02 | N/A |
| 52 Week Low | $0.71 | $2.08 |
| 52 Week High | $4.16 | $4.22 |
| Indicator | KOPN | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 49.89 |
| Support Level | $2.26 | $2.42 |
| Resistance Level | $2.44 | $2.65 |
| Average True Range (ATR) | 0.17 | 0.12 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 54.92 | 61.64 |
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.